DD204266A5 - Verfahren zur herstellung von lymphoblastoiden interferonen - Google Patents
Verfahren zur herstellung von lymphoblastoiden interferonen Download PDFInfo
- Publication number
- DD204266A5 DD204266A5 DD82243742A DD24374282A DD204266A5 DD 204266 A5 DD204266 A5 DD 204266A5 DD 82243742 A DD82243742 A DD 82243742A DD 24374282 A DD24374282 A DD 24374282A DD 204266 A5 DD204266 A5 DD 204266A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- leu
- ser
- glu
- asp
- ala
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8129937 | 1981-10-03 | ||
GB8208988 | 1982-03-26 | ||
GB08224871A GB2108510B (en) | 1981-10-03 | 1982-09-01 | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DD204266A5 true DD204266A5 (de) | 1983-11-23 |
Family
ID=27261323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD82243742A DD204266A5 (de) | 1981-10-03 | 1982-10-01 | Verfahren zur herstellung von lymphoblastoiden interferonen |
Country Status (19)
Country | Link |
---|---|
US (1) | US5089400A (ja) |
EP (1) | EP0076489B1 (ja) |
JP (2) | JPH06104066B2 (ja) |
KR (1) | KR920007665B1 (ja) |
AU (1) | AU561104B2 (ja) |
DD (1) | DD204266A5 (ja) |
DE (1) | DE3280174D1 (ja) |
DK (1) | DK170714B1 (ja) |
ES (2) | ES8504936A1 (ja) |
FI (1) | FI80719C (ja) |
GB (1) | GB2108510B (ja) |
GR (1) | GR76992B (ja) |
HU (1) | HU197047B (ja) |
IE (1) | IE54051B1 (ja) |
IL (1) | IL66920A0 (ja) |
NO (1) | NO166494C (ja) |
NZ (1) | NZ202058A (ja) |
PH (2) | PH21524A (ja) |
PT (1) | PT75643B (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
DE3220116A1 (de) | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
US4694071A (en) * | 1982-10-11 | 1987-09-15 | National Research Development Corporation | Polypeptides useful in vaccination against enteroviruses |
CA1252046A (en) * | 1982-11-04 | 1989-04-04 | Martin J. Cline | Methods for oncogenic detection |
JPS60118196A (ja) * | 1983-11-30 | 1985-06-25 | Takeda Chem Ind Ltd | インタ−フェロンの製造法 |
JPS6156199A (ja) * | 1984-08-27 | 1986-03-20 | Shionogi & Co Ltd | 新規ヒトインタ−フエロンα類 |
EP0194006B1 (en) * | 1985-02-01 | 1992-04-29 | Imperial Chemical Industries Plc | Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them |
GB8508685D0 (en) * | 1985-04-03 | 1985-05-09 | Minor P D | Peptides |
EP0200417B1 (en) * | 1985-04-30 | 1992-10-21 | Takeda Chemical Industries, Ltd. | Production of protein |
DE3685996T2 (de) * | 1985-06-11 | 1993-01-14 | Ciba Geigy Ag | Hybrid-interferone. |
DE3751409T2 (de) | 1986-04-15 | 1996-01-25 | Ciba Geigy Ag | Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze. |
TW218846B (ja) * | 1992-04-07 | 1994-01-11 | Ciba Geigy | |
US6261808B1 (en) | 1992-08-04 | 2001-07-17 | Replicon, Inc. | Amplification of nucleic acid molecules via circular replicons |
WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
US5733733A (en) * | 1992-08-04 | 1998-03-31 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
US5834202A (en) * | 1992-08-04 | 1998-11-10 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
US20020102236A1 (en) * | 1994-12-08 | 2002-08-01 | Taylor Peter William | Liposomal interferon hybrid compositions |
ATE207538T1 (de) | 1995-02-09 | 2001-11-15 | Behringwerke Ag | Verfahren zur produktion von proteinen |
US6087102A (en) * | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6685933B1 (en) * | 1998-07-28 | 2004-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Interferon α hybrids |
DE19919149A1 (de) * | 1999-04-27 | 2000-11-16 | Wieser Raimund J | Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere |
EP2292652A2 (en) | 2000-11-03 | 2011-03-09 | Pestka Biomedical Laboratories, Inc. | Interferons uses and compositions related thereto |
WO2002088161A1 (en) * | 2001-05-02 | 2002-11-07 | Pepgen Corporation | Method for expression of human interferon alpha 1 in pichia pa storis |
FR2825716B1 (fr) | 2001-06-11 | 2004-09-24 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'ifn alpha 7 |
KR101128055B1 (ko) * | 2004-12-20 | 2012-03-29 | 카딜라 핼쓰캐어 리미티드 | 고 수준의 인터페론 베타를 제조하는 방법 |
CN108541269B (zh) | 2016-11-21 | 2020-06-02 | 日东电工株式会社 | 粘合片 |
WO2018092904A1 (ja) | 2016-11-21 | 2018-05-24 | 日東電工株式会社 | 粘着シート |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA796175B (en) * | 1978-11-24 | 1980-11-26 | Hoffmann La Roche | Purified proteins and process therefor |
AU538665B2 (en) * | 1979-10-30 | 1984-08-23 | Juridical Foundation, Japanese Foundation For Cancer Research | Human interferon dna |
NO164037C (no) * | 1980-01-08 | 1990-08-22 | Biogen Inc | Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type. |
DE3005897A1 (de) * | 1980-02-16 | 1981-09-03 | Hoechst Ag, 6000 Frankfurt | Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus |
IE57069B1 (en) * | 1980-04-03 | 1992-04-22 | Biogen Inc | Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon |
EP0042246B1 (en) * | 1980-06-12 | 1987-03-18 | The Cancer Institute Of Japanese Foundation For Cancer Research | Plasmid |
ES506955A0 (es) * | 1980-11-10 | 1983-02-01 | Genentech Inc | Un procedimiento para producir un polipeptido antiviral. |
GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
-
1982
- 1982-09-01 GB GB08224871A patent/GB2108510B/en not_active Expired
- 1982-09-30 IL IL66920A patent/IL66920A0/xx unknown
- 1982-09-30 KR KR8204446A patent/KR920007665B1/ko active
- 1982-10-01 GR GR69416A patent/GR76992B/el unknown
- 1982-10-01 EP EP82109094A patent/EP0076489B1/de not_active Expired - Lifetime
- 1982-10-01 AU AU88958/82A patent/AU561104B2/en not_active Ceased
- 1982-10-01 ES ES516154A patent/ES8504936A1/es not_active Expired
- 1982-10-01 PT PT75643A patent/PT75643B/pt not_active IP Right Cessation
- 1982-10-01 DE DE8282109094T patent/DE3280174D1/de not_active Expired - Lifetime
- 1982-10-01 HU HU823164A patent/HU197047B/hu not_active IP Right Cessation
- 1982-10-01 FI FI823356A patent/FI80719C/fi not_active IP Right Cessation
- 1982-10-01 DK DK437382A patent/DK170714B1/da not_active IP Right Cessation
- 1982-10-01 IE IE2385/82A patent/IE54051B1/en not_active IP Right Cessation
- 1982-10-01 PH PH27947A patent/PH21524A/en unknown
- 1982-10-01 DD DD82243742A patent/DD204266A5/de not_active IP Right Cessation
- 1982-10-01 NZ NZ202058A patent/NZ202058A/en unknown
- 1982-10-01 NO NO823314A patent/NO166494C/no unknown
- 1982-10-04 JP JP57174426A patent/JPH06104066B2/ja not_active Expired - Lifetime
-
1983
- 1983-12-16 ES ES528141A patent/ES528141A0/es active Granted
-
1985
- 1985-06-26 PH PH32461A patent/PH23119A/en unknown
-
1989
- 1989-03-07 US US07/320,185 patent/US5089400A/en not_active Expired - Fee Related
-
1994
- 1994-07-05 JP JP6153677A patent/JP2612149B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0076489B1 (de) | Desoxyribonucleinsäuren, rekombinante Desoxyribonucleinsäuren, sie enthaltende Wirte, Polypeptide und Verfahren zu ihrer Herstellung | |
DE3382771T2 (de) | Ein Gamma-Interferon kodierendes synthetisches Gen. | |
DE3177288T2 (de) | Reife menschliche leukozyten-interferone, verfahren zu ihrer bacteriellen herstellung, zwischenprodukte hierfuer und zusammensetzungen diese enthaltend. | |
EP0168342B1 (de) | Verfahren zur Herstellung von Thrombin-Inhibitoren | |
DE3685996T2 (de) | Hybrid-interferone. | |
DE3220116C2 (ja) | ||
EP0218825A1 (en) | Cysteine-depleted muteins of interferon-beta, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins | |
DD159782A5 (de) | Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanleukozyten-interferon aufweisendes polypeptids | |
EP0161504B1 (de) | Herstellung von Polypeptiden mit Human-Gammainterferon-Aktivität | |
DD209477A5 (de) | Verfahren zur herstellung von mikroorganismen | |
DD212748A5 (de) | Verfahren zur bildung doppelstraengiger, hybride human-leukozyten-interferone kodierender dns | |
HU193512B (en) | Process for preparing hybride interferones from human erythrocytes | |
DE3144469A1 (de) | Hybride human-leukozyten-interferone | |
DE3781217T2 (de) | Herstellung von verwandten polypeptiden des bindungsfaktors. | |
EP0115613B1 (de) | DNA-Sequenzen, deren Herstellung, diese Sequenzen enthaltende Plasmide und deren Verwendung zur Synthese eukaryotischer Genprodukte in Prokaryoten | |
DD219212A5 (de) | Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors | |
DE3751409T2 (de) | Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze. | |
US4695543A (en) | Alpha Interferon GX-1 | |
DE3490055T1 (de) | Menschliches Leukozyteninterferon N und Verfahren zu dessen Herstellung in Bakterienzellen | |
AT394208B (de) | Verfahren zur herstelluung von vektoren | |
AT394207B (de) | Verfahren zur herstellung von human-leukozyteninterferonen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |